Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||0.00%||8.00||0.7%||$559.23m|
|GILD||Gilead Sciences, Inc.||-0.45%||64.60||1.0%||$470.31m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.27%||478.32||2.7%||$432.27m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.25%||216.48||1.9%||$372.99m|
|ALXN||Alexion Pharmaceuticals, Inc.||0.00%||153.73||2.0%||$315.33m|
|EXAS||EXACT Sciences Corp.||1.48%||129.89||18.4%||$197.74m|
|NBIX||Neurocrine Biosciences, Inc.||0.00%||92.97||4.9%||$172.50m|
|CRSP||CRISPR Therapeutics AG||0.47%||121.45||0.6%||$170.15m|
|TXG||10X Genomics, Inc.||0.00%||197.36||0.0%||$149.02m|
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.